Shift4

Step 01 — Business Model, Value Chain & Unit Economics

Shift4 Payments (NYSE: FOUR) · 2026-06-14 · Sector: General Corporate (payments/fintech) + TFS hybrid

1. Key Findings

• Shift4 makes money two structurally different ways now: (1) software-integrated payment processing (the legacy core — a take-rate on payment volume, bundled with owned POS hardware/software), and (2) tax-free-shopping (TFS) commissions via Global Blue (a net, agent-basis fee on tourist VAT refunds) [S1][S2]. The first is recurring/volume-linked and US-centric; the second is high-margin but cross-border-tourism-cyclical [S2].
• The core economic engine is volume × blended spread. Spread structurally compresses as Shift4 wins larger merchants (enterprise spread <20 bps vs SMB 70–100 bps), so volume grows faster than payments revenue (FY2025 volume +27% vs payments-based +16%) — by design, not weakness, if GRLNF dollars keep compounding [S1][S3].
• The strategic flywheel is gateway → end-to-end conversion ("delete the parts"): take a merchant's gateway-only volume and convert it to Shift4's full stack (hardware + software + processing), multiplying revenue per merchant without newth customer acquisition [S1][S3].
• Net for thesis: positive on model durability (integrated, recurring, switching-cost-rich), but the disclosure work flags that the organic version of this engine is decelerating (+11% Q1'26) and the TFS leg adds a new cyclical beta [S4][S5].

2. Implications for Thesis and Valuation

• Forecast off GRLNF and Adjusted EBITDA, not gross revenue (which is grossed-up by pass-through network fees) and not GAAP EPS (distorted by acquisition amortization + tripled interest) [S1][S6].
• The two legs need separate forecast logic: payments = volume × compressing spread + subscription attach; TFS = travel/luxury-cycle × ~2.2–2.5% take, seasonally Q3-heavy, China-outbound-geared [S2].
• Switching costs + owned vertical software (stadiums/gaming/hospitality) are the moat to test in Step 10; spread compression and organic deceleration are the bear levers to test in Steps 03/12/13 [S3][S4].

3. Objective

Explain how Shift4 actually earns a dollar — products, customers, pricing, distribution, value chain, switching points, and the unit economics that matter — before any market or valuation analysis.

4. Narrative Analysis

The three-pillar "Shift4 Model" [S1]: (1) a payments platform (omni-channel card acceptance + processing, used either as a gateway interoperable with third-party processors, or end-to-end as the single vendor for acceptance, devices, POS software and BI); (2) technology solutions (SkyTab POS / SkyTab Mobile / SkyTab Venue, Lighthouse BI, Shift4Shop e-commerce, Marketplace integrations, The Giving Block crypto-donations, and now Global Blue's TFS Services); and (3) sales & distribution through internal teams plus a partner network of ISVs and VARs and direct enterprise relationships (stadiums, resorts, airlines) [S1].

How the dollar is earned. The core is a take-rate on payment volume — payments-based revenue is driven by a percentage of dollars processed plus fixed/per-transaction/minimum fees [S1]. Shift4 keeps only the acquirer net spread ("the plus"), not the full merchant discount rate (interchange goes to issuers, assessments to networks) [S2]. On top sits subscription & other (POS SaaS, terminal/statement fees, BI, hardware, residuals) — the stickier, higher-quality layer (FY2025 $454M, +33%) [S1]. The newest leg, TFS revenue ($255M H2'25), is a commission on tourist VAT refunds, recognized net (Shift4 acts as agent) at the point of customs-validated refund — structurally different: travel-cyclical, FX-exposed, and seasonally weighted to Q3 (summer travel) [S1][S2].

The flywheel. Shift4's signature strategy is converting gateway-only merchants to end-to-end and "deleting the parts" (eliminating the third-party gateway, device, gift-card and residual fees a merchant otherwise pays), capturing far higher revenue per merchant [S1][S3]. End-to-end fees are "significantly higher" per transaction than gateway-only [S1]. This is the engine behind years of GRLNF compounding and margin expansion (Adj EBITDA margin 31.6%→50% over the cycle) [S3].

The structural tension. Because Shift4 has moved up-market (stadiums, airlines, large hotels), blended spread compresses (FY2025 ~61 bps, Q4 ~57 bps) as enterprise volume (<20 bps) dilutes the SMB mix (70–100 bps) [S1][S2]. Management's defense: absolute GRLNF and EBITDA still compound, NRR is 115%, and partner revenue-share fell 21.4%→11.8% (go-to-market efficiency) [S3]. The bear's concern (Steps 03/12): spread compression + the now-decelerating organic GRLNF (+11% Q1'26) mean the flywheel may be maturing [S4][S5].

5. Evidence and Sources

• Three pillars, products, revenue model, one reportable segment, no merchant >3% of revenue [S1].
• Revenue by type FY23/24/25: Payments-based $2,386M/$2,990M/$3,471M; TFS $0/$0/$255M; Subscription $179M/$341M/$454M [S1].
• Spread economics by merchant size (Bain): micro 100–200 bps, SMB 70–100 bps, enterprise <20 bps [S2]; payfac/own-MID up to ~100 bps [S2].
• FY2025 volume +27% vs payments-based +16% = the mix/compression effect [S1].
• Cycle improvement: margin 31.6%→50%, NRR 99%→115%, partner-rev-share 21.4%→11.8% [S3].
• TFS net/agent recognition, Q3-seasonal, China-outbound-geared (~40% pre-COVID SIS) [S2].

6. Assumption Register Updates

Reinforces A04 (spread compression, mix-driven) and A05 (organic-vs-reported wedge). No new assumptions; the two-leg forecast logic is flagged for Step 13.

7. Tables and Calculations

Revenue model map

Leg	Pricing	Recurring?	Driver	FY2025	Cyclicality
Payments-based (incl. DCC, TFS comm. in MD&A view)	% of volume + per-txn	Yes (volume-linked)	Volume × spread	$3,471M	Low (consumer card spend)
TFS (VAT-refund)	~2.2–2.5% of purchase, net	Yes but seasonal	Tourist luxury SIS	$255M (H2)	High (travel/luxury, China)
Subscription & other	SaaS/fees/hardware	Yes (stickiest)	Installed base	$454M	Low

Unit economics that matter (and the misleading ones)

Metric	Why it matters	Watch-out
Blended spread (~61 bps)	Core take rate	Compressing; disclosed selectively [S4]
GRLNF / volume	Cleaner yield	Use vs the redefined "volume" [S4]
Organic GRLNF growth	True demand signal	+11% Q1'26 — decelerating [S5]
NRR (115%), Adj EBITDA margin (50%)	Quality/stickiness	Single-disclosure (Investor Day) [S3]
Gross revenue	—	Misleading — grossed up by network-fee pass-through [S6]
GAAP EPS	—	Misleading — acq. amort + tripled interest [S1]

8. Open Questions and Data Gaps

• Is organic deceleration structural (maturing flywheel / spread floor) or transitory (legacy deprecation + travel softness)? → Steps 03/05/12/13.
• TFS through-cycle economics and China-outbound sensitivity → Steps 02/11/15.
• Subscription mix trajectory (the quality layer) → Step 03.

Source Index

Tag	Document	Section	Date
S1	FOUR_financials/sec_filings/10K_business_and_segments.md (FY2025 10-K)	§1–8	2026-06-14
S2	FOUR_financials/industry/payments_and_tfs_market.md	Parts A & B	2026-06-14
S3	FOUR_financials/presentations/DECK_InvestorDay_2025-02_extract.md	KPIs/strategy	2025-02
S4	FOUR_disclosure_map.md	volume/spread, G1/G6	2026-06-14
S5	FOUR_financials/earnings/quarterly_kpis.md	organic GRLNF	2026-06-14
S6	FOUR_financials/industry/competitive_landscape.md	revenue-basis note	2026-06-14

Step 04 — Financial Statement Quality & Adjustments

Shift4 Payments (NYSE: FOUR) · 2026-06-14

1. Key Findings

• Shift4's "adjusted" metrics flatter, but its accounting is more defensible than bears claim. FY2025 GAAP→Adjusted EBITDA gap is +$212M (+28%), of which ~$170M is arguably recurring (equity comp $85M + acquisition/integration $84M) for a serial acquirer [S1][S2]. Use a normalized EBITDA ≈ $870M (Adj EBITDA $970M − SBC $85M − ~½ run-rate integration), not the reported $970M, for valuation [S1].
• The fraud case did not stick. The only short report (Blue Orca, Apr 2023) alleged roll-up/EBITDA-inflation; the securities class action built on the same facts was DISMISSED WITH PREJUDICE (Jan 2025, no scienter); the only regulator outcome is a narrow $750K SEC settlement for undisclosed family-member compensation (a disclosure hygiene matter, now closed) [S3].
• Quality positives: SBC is modest (~4% of GRLNF, ~9% of Adj EBITDA) — far below Toast/Block; and across ~14 acquisitions there are zero goodwill impairments [S2][S4]. Quality negatives: Adjusted FCF adds back "strategic capex" and had a settlement reclass that restated prior periods; add-backs have grown 4→9 items [S5].
• The live tail risk: Rook (Isaacman) has pledged 15,000,000 Class A shares against a margin loan — a default could force-sell up to 15M shares; not eliminated by the Up-C collapse [S3].
• Net for thesis: mixed. Earnings are usable with a haircut; the accounting-fraud thesis is largely refuted; but the adjusted metrics flatter and the margin pledge is a real tail.

2. Implications for Thesis and Valuation

• Feed valuation with normalized EBITDA ~$870M and expense SBC (treat as real dilution, ~$85M/yr) [S1].
• Add back acquisition-intangible amortization (~$91M/yr from the Global Blue $1,816M / 20-yr merchant intangible) for EV/EBIT, but recognize it represents real customer-acquisition cost (Step 09 ROIC) [S6].
• Discount management's Adjusted FCF (strategic-capex add-back) — use a stricter FCF = OCF − all capex; FY2025 ≈ $500M company-defined, lower on a strict basis [S5].
• Margin-pledge tail → EX-/INSIDER- watchlist (Steps 17/18) [S3].

3. Objective

Convert reported numbers into a usable normalized earnings base; test whether "one-time" adjustments recur; and run the mandatory adversarial sweep.

4. Narrative Analysis

GAAP → Adjusted bridge (FY2025). Net income $147M builds to EBITDA $758M (+$190M interest, −$59M interest income, +$48M tax, +$432M D&A), then to Adjusted EBITDA $970M via $212M of add-backs [S1]. The add-backs split into two buckets: arguably recurring — equity comp ($85M) and acquisition/restructuring/integration ($84M, structural for a company doing ~3 deals/yr); and genuinely one-time — loss on debt extinguishment ($12M), impairment ($9M), gain on sale of subs (−$19M), TRA change ($4M), contingent-liability revaluation (−$4M) [S1][S2]. FX & other ($41M) is partly recurring (Global Blue EUR exposure now structural) [S1]. Normalizing — keeping SBC and ~half of integration as real costs — yields EBITDA ≈ $850–885M (use ~$870M) [S1].

SBC is a genuine positive. At ~$85M, SBC is ~4% of GRLNF and ~9% of Adj EBITDA — modest versus Toast/Block (where SBC ≈ FCF) [S2][S4]. Dilution has been ~1.2%/yr historically, partly offset by buybacks [S4]. This is a real quality differentiator versus the SaaS-payments peers.

Adjusted FCF is the softer metric. Definition drift matters: Shift4 adds back "nonrecurring strategic capital expenditures" to Adjusted FCF (inflates it), reworded the settlement basis multiple times, and reclassified "settlement activity, net" operating→financing in Q4'24 with prior periods restated [S5]. Treat company Adjusted FCF (~$500M FY2025, ~52% conversion) as an upper bound; FY2026 conversion guided down to ~42% on Global Blue tax-free-shopping working-capital seasonality [S5].

Acquisition-intangible amortization is large and growing — the Global Blue merchant-relationship intangible alone is $1,816M amortized over 20 years (~$91M/yr) [S6]. Non-cash, so added back for EV/EBIT, but it is the accounting footprint of $4.5B+ of M&A and a real reinvestment cost (Step 09).

Adversarial sweep (mandatory). Shift4 carries a heavier adversarial file than most peers, but little has been substantiated [S3]:

• Blue Orca (Apr 19, 2023) — the only short report. Alleged distributor-buyout COGS capitalization (~34% EBITDA inflation), amortization-schedule extension, sponsor-bank collateral booked as OCF, and CEO margin-call risk. Stock −9–12%. Never retracted, but the legal theory failed. [S3]
• SEC order 34-102146 (Jan 10, 2025) — $750K penalty for ~$4.7M undisclosed related-person (family) compensation, 2020–2023. Disclosure violation, not accounting fraud; settled (neither admit nor deny); closed. Not about any aircraft/"Continental" entity (bears conflate). [S3]
• Securities class action (E.D. Pa.) — built on the 2022 CAC-classification restatement; DISMISSED WITH PREJUDICE Jan 22, 2025 (court twice found no scienter). The restatement was classification-only, no KPI impact. [S3]
• Merchant-billing class action (Aug 2023) + merchant-advocacy press — fee-obfuscation/overcharging claims from merchants; ongoing, lower-stakes commercial dispute. [S3]
• Governance: dual-class super-voting + TRA eliminated (Feb 2026 Up-C collapse); aircraft RPT restructured (Jan 2026, still related-party ~$1M/yr); Searchlight clean; but the Rook 15,000,000-share margin pledge is LIVE (forced-sale tail). [S3]
• Global Blue deal — no litigation/opposition; independent fairness opinion; clean. [S3]
• ~21–35% short interest = a crowded valuation/growth-quality short (roll-up accounting, organic-vs-acquired mix, leverage, 2026 guide below consensus), not an active fraud campaign; no new short report since Blue Orca [S3].

Verdict: The accounting-fraud thesis is largely refuted by the court dismissal and the modest SBC/zero-impairment record, but the disclosure-management pattern (add-back creep, FCF add-backs, metric redefinitions from Step 00) warrants haircutting the adjusted metrics. The margin pledge is the one live, mechanical tail risk.

5. Evidence and Sources

• FY2025 GAAP→Adj EBITDA bridge ($147M→$758M→$970M; $212M add-backs itemized) [S1].
• SBC $85M (~4% GRLNF); zero goodwill impairments across ~14 deals [S2][S4].
• Adj FCF strategic-capex add-back + settlement reclass/restatement [S5].
• Global Blue merchant intangible $1,816M / 20-yr (~$91M/yr amort) [S6].
• Adversarial: Blue Orca (2023), SEC $750K (Jan 2025), class action dismissed w/ prejudice (Jan 2025), merchant suit (2023), Rook 15M-share pledge live, ~34% short = quality short [S3].

6. Assumption Register Updates

Revised A06 → normalized EBITDA ~$870M (was ~$885M) after explicit SBC expensing + ½ integration haircut. New flag for Step 14: add back ~$91M/yr acquisition amortization for EV/EBIT; use strict FCF (not company Adjusted FCF).

7. Tables and Calculations

FY2025 GAAP→Adjusted EBITDA bridge ($M)

Line	$M	Recurring?
Net income	147	—
+ Interest expense	190	—
− Interest income	(59)	—
+ Income tax	48	—
+ D&A	432	(incl. ~$91M acq. amort)
= EBITDA	758
+ Equity-based comp	85	Yes (real cost)
+ Acq./restructuring/integration	84	~½ recurring
+ FX & other nonrecurring	41	Partly
+ Loss on debt extinguishment	12	No
+ Impairment	9	No
− Gain on sale of subs	(19)	No
+ Change in TRA	4	No
− Revaluation contingent liab.	(4)	No
= Adjusted EBITDA	970
Normalized EBITDA (− SBC − ½ integration)	~870	valuation base
Source [S1].

8. Open Questions and Data Gaps

• Strict (not Adjusted) FCF series — re-derive in Step 09/14 [S5].
• Does the Rook margin pledge get unwound? (forced-sale tail) → Step 17 [S3].
• Blue Orca's distributor-capitalization critique vs current intangibles — monitor amortization vs cash CAC (Step 09) [S3].

Source Index

Tag	Document	Section	Date
S1	FY2025 10-K Table 19 (10K_FY2025_financial_tables.xlsx)	Adj EBITDA bridge	2026-02-27
S2	FOUR_definition_changes.md §5	add-back creep	2026-06-14
S3	FOUR_financials/other/adversarial_sweep.md	full sweep	2026-06-14
S4	FOUR_financials/other/ma_inventory.md + Investor Day	SBC/impairments	2026-06-14
S5	FOUR_definition_changes.md §6	Adj FCF drift	2026-06-14
S6	FOUR_financials/sec_filings/capital_structure_and_GB_acquisition.md	GB PPA	2026-06-14

Step 12 — Conference-Call Analyst Debate & Bull vs Bear

Shift4 Payments (NYSE: FOUR) · 2026-06-14

1. Key Findings

• The Wall Street debate has migrated from "how big can this get?" to "how much of the growth is real and durable?" Analyst Q&A over 14 calls increasingly centers on organic vs acquired growth, spread compression, Global Blue margin/integration, and leverage — the same concerns the crowded ~34% short embodies [S1][S2].
• The single dominant question now: is the organic deceleration (+11% Q1'26) structural or transitory? Management frames it as transitory (legacy-deprecation drag + travel); skeptics see a maturing flywheel + spread floor [S1].
• Net for thesis: the debate is finely balanced — a depressed-multiple, founder-aligned compounder vs a decelerating, optics-flattered, levered roll-up. Resolution hinges on H2'26 organic + Global Blue synergy delivery [S1][S2].

2. Implications for Thesis and Valuation

• The market is pricing meaningful skepticism (~7× fwd, 34% short) — variant perception exists if organic re-accelerates and Global Blue delivers (Step 16) [S2].
• The bull/bear bullets below frame the scenario weights (Step 15) and the memo (Step 19) [S1].

3. Objective

Infer the main bull vs bear debate from analyst question trends and management responses across calls; distill to 3 bull + 3 bear points.

4. Narrative Analysis

Question themes across calls (trend).

• Organic vs acquired growth — rising and now dominant. From occasional in 2023 to the central question in 2025–26; analysts repeatedly press for the ex-Global Blue/ex-M&A organic figure, which is why management formalized "organic GRLNF" in Q1'26 (a disclosure response to the pressure) [S1][S3].
• Spread / take-rate compression — recurring; management consistently answers "mix-driven, GRLNF dollars compound" [S1].
• Global Blue margin + integration + working capital — rising since Q3'25; analysts probe the EBITDA-margin dilution and the FCF-conversion step-down to 42% [S1].
• Leverage / capital allocation — rising post-deal; questions on deleveraging path (~3.4×), buyback vs debt paydown, and the preferred [S1].
• Travel/consumer trends — recurring; restaurants/hotels corridor, and now Global Blue travel (China, Middle East) [S1].
• Backlog/visibility — newly salient; with the backlog metric removed in Q1'26, expect analysts to press on forward visibility at Q2'26 [S3].
• 2026 guide below consensus — the proximate cause of the de-rating; "growth deceleration" narrative [S2].

Management's posture. Generally responsive and confident, but the tone has shifted from Isaacman's growth-grab to Lauber/Cruz's "FCF-per-share / ROIC>WACC / disciplined" maturation — and the disclosure changes (backlog removed, target softened) suggest the answers are getting more defensive as organic decelerates [S3]. Whether the market opportunity is expanding (the $1.4T funnel narrative) or the core is maturing is exactly the contested point [S1].

Moat signals from transcripts: customer stickiness/NRR strong; cross-sell wins real (Eigen→casinos); but spread compression and the legacy-deprecation drag are the offsetting tells [S1].

5. Bull Case — 3 bullets

1. Durable, founder-aligned compounder on sale. ~7× forward Non-GAAP P/E, −62% off high, with an advantaged-CAC integrated-payments machine (B+ M&A record, zero impairments) plus a newly-added wide-moat TFS duopoly — and the founder buying ~$50M personally into the decline [S1][S2].
2. Global Blue optionality is underpriced. A high-margin (~40% EBITDA), asset-light, ~70%-share franchise bought at a reasonable ~13×, with a $1.4T cross-sell funnel, ~$80M synergies, EPS-accretion year 1, and a structurally under-penetrated (⅓-addressed) TFS market [S1].
3. The organic deceleration is partly transitory. Q1'26 +11% absorbs a ~400 bps intentional-legacy-deprecation drag (→ ~+15% underlying) plus travel softness; stadiums/gaming/international runway + cross-sell could re-accelerate as deprecation laps [S3].

6. Bear Case — 3 bullets

1. The organic engine is structurally decelerating. Organic GRLNF +11% and falling from 25%+, blended spread compressing (~57 bps), and the forward-volume backlog metric removed the same quarter — a maturing flywheel with reduced visibility; the 25%+ era is over [S1][S3].
2. Optics + leverage mask the truth. The +46–49% headline is Global-Blue-inflated; add-backs grew 4→9, Adjusted FCF adds back "strategic capex," FCF conversion is dropping to 42%, the balance sheet is ~3.4–3.7× levered + a $1B preferred, and consolidated ROIC is below WACC [S2][S3].
3. It's a crowded short for substantive reasons. ~34% short interest reflects roll-up-accounting skepticism (Blue Orca), a $750K SEC disclosure settlement, a live 15M-share founder margin pledge, discretionary/travel cyclicality, and 2026 guidance below consensus [S2].

7. Tables and Calculations

Debate scorecard

Theme	Bull view	Bear view	Trend
Organic growth	transitory dip (~15% underlying)	structural deceleration	bear-leaning near-term
Global Blue	underpriced wide-moat leg	levered, margin-dilutive, unproven	unresolved
Spread	mix-driven, GRLNF compounds	compression to a floor	bear-leaning
Capital structure	manageable, deleveraging	levered + preferred overhang	neutral
Valuation	~7× = mispriced	value trap / falling knife	the crux

8. Open Questions and Data Gaps

• H2'26 organic GRLNF + any forward-visibility metric (resolves bull/bear #1) → Step 16/18 [S3].
• Global Blue synergy/margin convergence (resolves #2) → Step 16 [S1].
• Does the short cover or press? (squeeze vs falling knife) → Step 17 [S2].

Source Index

Tag	Document	Section	Date
S1	FOUR_financials/earnings/transcript_Q3_2025.md / Q4_2025.md / Q1_2026.md	analyst Q&A	2025–2026
S2	FOUR_financials/other/adversarial_sweep.md §7 + current_market_snapshot.md	short thesis/consensus	2026-06-14
S3	FOUR_disclosure_map.md + quarterly_kpis.md	backlog/organic	2026-06-14